Whether you are using brand-name Mounjaro, Zepbound, or compounded tirzepatide from a pharmacy, the dosage principles remain the same
Predictors of weight-loss response with glucagon-like peptide-1 receptor agonist treatment among adolescents with severe obesity
Who Can Benefit from Limi Ferti
If you are traveling halfway across the world, you might find that your usual dose time now falls in the middle of the night
This comes as the American College of Cardiology (ACC) released its five top trends in cardiovascular medicine in 2025, including Anti-Obesity Drugs: Cardiovascular Benefit Beyond Weight Loss. The ACC reports that semaglutide and tirzepatide both demonstrate remarkable cardiovascular benefits that extend beyond weight management. Clinical trials show these medications can reduce the risk of major adverse cardiovascular events by up to 20% in patients with obesity and preexisting cardiovascular conditions
In an associated Commentary titled Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward, Juan Brito, MD , from the Mayo Clinic, and coauthors, stated the following: this study stands out for its large scale and robust methodology
